Loading clinical trials...
Loading clinical trials...
The EAP is intended to provide a treatment option for patients with proven or probable serious or life-threatening invasive fungal infection (in accordance with the EORTC-MSGERC criteria) who have exh...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Basilea Pharmaceutica
NCT06105411 · Invasive Fungal Infections
NCT06537726 · Leukemia, Leukemia, Myeloid, and more
NCT05688592 · Invasive Fungal Infections
NCT06640296 · Invasive Fungal Infections, Prophylaxis, and more
NCT07120581 · Invasive Fungal Infections, Hyperbaric Oxygen Therapy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions